abstract |
The present invention relates to compounds that act as inhibitors of BCL6 (B-cell lymphoma 6) activity. The present invention also relates to processes for the preparation of these compounds, pharmaceutical compositions comprising them, and their use in the treatment of proliferative disorders such as cancer, as well as other diseases or conditions in which BCL6 activity is implicated. |